ZA988064B - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
ZA988064B
ZA988064B ZA988064A ZA988064A ZA988064B ZA 988064 B ZA988064 B ZA 988064B ZA 988064 A ZA988064 A ZA 988064A ZA 988064 A ZA988064 A ZA 988064A ZA 988064 B ZA988064 B ZA 988064B
Authority
ZA
South Africa
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
ZA988064A
Inventor
Sigfried Benjam Christensen Iv
Renee Louise Desjarlais
Cornelia Jutta Forster
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA988064B publication Critical patent/ZA988064B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA988064A 1997-09-04 1998-09-03 Protease inhibitors ZA988064B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5752797P 1997-09-04 1997-09-04

Publications (1)

Publication Number Publication Date
ZA988064B true ZA988064B (en) 1999-05-28

Family

ID=22011125

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988064A ZA988064B (en) 1997-09-04 1998-09-03 Protease inhibitors

Country Status (10)

Country Link
EP (1) EP1015438A4 (en)
JP (1) JP2001514257A (en)
AU (1) AU9300298A (en)
CA (1) CA2302361A1 (en)
CO (1) CO4970736A1 (en)
MA (1) MA26540A1 (en)
PE (1) PE115699A1 (en)
SA (1) SA98190653A (en)
WO (1) WO1999011637A1 (en)
ZA (1) ZA988064B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6534498B1 (en) 1999-11-10 2003-03-18 Smithkline Beecham Corporation Protease inhibitors
JP2003513972A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EA005893B1 (en) 2000-03-21 2005-06-30 Смитклайн Бичам Корпорейшн Protease inhibitors
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
WO2003062192A1 (en) 2002-01-17 2003-07-31 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
KR100962972B1 (en) 2002-07-26 2010-06-09 주식회사유한양행 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
DE102004008141A1 (en) 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidine compounds and their use as binding partners for 5-HT5 receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225172A (en) * 1983-06-03 1984-12-18 Yamanouchi Pharmaceut Co Ltd Novel guanidinothiazole derivative and its preparation

Also Published As

Publication number Publication date
CO4970736A1 (en) 2000-11-07
JP2001514257A (en) 2001-09-11
WO1999011637A1 (en) 1999-03-11
EP1015438A1 (en) 2000-07-05
AU9300298A (en) 1999-03-22
EP1015438A4 (en) 2000-11-08
PE115699A1 (en) 2000-01-13
MA26540A1 (en) 2004-12-20
CA2302361A1 (en) 1999-03-11
SA98190653A (en) 2005-12-03

Similar Documents

Publication Publication Date Title
IL131661A0 (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
PL349192A1 (en) Protease inhibitors
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL328307A1 (en) Serinic protease inhibitors
EP0744948A4 (en) Protease inhibitors
IL132088A0 (en) Protease inhibitors
ZA983841B (en) Protease inhibitors
EP1093367A4 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
ZA988479B (en) Protease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
EP1067894A4 (en) Protease inhibitors
EP1079821A4 (en) Protease inhibitors
ZA988064B (en) Protease inhibitors
EP1140897A4 (en) Protease inhibitors
EP1086083A4 (en) Protease inhibitors
EP0975612A4 (en) Protease inhibitors
ZA983097B (en) Protease inhibitors
ZA977032B (en) Protease inhibitors
GB9420277D0 (en) Protease inhibitors
GB9725783D0 (en) Inhibitors
GB9727371D0 (en) Inhibitors